These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1837158)

  • 1. Antagonism of EEGraphic and behavioural effects of methamphetamine by selective receptor blockers (SCH 23390 and raclopride) in the rabbit.
    Bo P; Marchioni E; Dallocchio C; Albergati A; Savoldi F
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):803-15. PubMed ID: 1837158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of the EEG profile of neuroleptics selective for D-1 or D-2 dopamine receptors in the rabbit.
    Bo P; Savoldi F
    Pharmacol Res; 1992; 26(1):67-74. PubMed ID: 1387476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.
    Lublin H; Gerlach J; Peacock L
    Psychopharmacology (Berl); 1993; 112(2-3):389-97. PubMed ID: 7871047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of SCH 23390 and raclopride on cocaine-induced analepsis and EEG arousal in rabbits.
    Yoshida K; Gjerde DK; Carino MA; Halpern LM; Horita A
    Neuropharmacology; 1993 May; 32(5):487-92. PubMed ID: 8100623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronization of the EEG and sedation induced by neuroleptics depend upon blockade of both D1 and D2 dopamine receptors.
    Bo P; Ongini E; Giorgetti A; Savoldi F
    Neuropharmacology; 1988 Aug; 27(8):799-805. PubMed ID: 2905785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of haloperidol and raclopride in the paw test are influenced similarly by SCH 39166.
    Prinssen EP; Ellenbroek BA; Stamatovic B; Cools AR
    Eur J Pharmacol; 1993 Feb; 231(2):275-80. PubMed ID: 8095900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive and negative interactions in the behavioural expression of D1 and D2 receptor stimulation in a model of Parkinsonism: role of priming.
    Morelli M; Fenu S; Cozzolino A; Di Chiara G
    Neuroscience; 1991; 42(1):41-8. PubMed ID: 1830642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of dopamine D-1 and D-2 receptor agonists on EEG activity and behaviour in the rabbit.
    Ongini E; Caporali MG
    Neuropharmacology; 1987 Apr; 26(4):355-60. PubMed ID: 2953987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of specific dopamine D1 and D2 receptor antagonists and agonists and neuroleptic drugs on emotional defecation in a rat model of akathisia.
    Sachdev PS; Saharov T
    Psychiatry Res; 1998 Dec; 81(3):323-32. PubMed ID: 9925183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys: antiamphetamine effects and extrapyramidal side effects.
    Peacock L; Hansen L; Mørkeberg F; Gerlach J
    Neuropsychopharmacology; 1999 Jan; 20(1):35-43. PubMed ID: 9885783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity.
    Marin C; Parashos SA; Kapitzoglou-Logothetis V; Peppe A; Chase TN
    Pharmacol Biochem Behav; 1993 May; 45(1):195-200. PubMed ID: 8516358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    Protais P; Chagraoui A; Arbaoui J; Mocaër E
    Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of forward locomotion by SCH-23390 and raclopride in d-amphetamine-treated rats.
    Salmi P; Malmgren K; Svensson TH; Ahlenius S
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):593-9. PubMed ID: 9686934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats.
    Mohd-Yusof A; Veliz A; Rudberg KN; Stone MJ; Gonzalez AE; McDougall SA
    Psychopharmacology (Berl); 2016 Mar; 233(5):893-903. PubMed ID: 26650612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
    Iorio LC; Cohen M; Coffin VL
    J Pharmacol Exp Ther; 1991 Jul; 258(1):118-23. PubMed ID: 1830098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of D1 and D2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced up-regulation of zif/268 mRNA expression in rat forebrain.
    Wang JQ; McGinty JF
    J Neurochem; 1995 Dec; 65(6):2706-15. PubMed ID: 7595569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
    Lublin H; Gerlach J; Mørkeberg F
    Psychopharmacology (Berl); 1994 Apr; 114(3):495-504. PubMed ID: 7855208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
    Wardas J; Pietraszek M; Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raclopride, but not SCH 23,390, induces maldirected jumping in rats trained to perform a run-climb-run behavioral task.
    Senyuz L; Fowler SC
    Psychopharmacology (Berl); 1993; 112(4):518-20. PubMed ID: 7871066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease.
    Ishida Y; Todaka K; Kuwahara I; Ishizuka Y; Hashiguchi H; Nishimori T; Mitsuyama Y
    Brain Res; 1998 Oct; 809(1):107-14. PubMed ID: 9795171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.